Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1100262	瑞格列奈胶囊	repaglinide	Capsule	Chemical Drugs(5)	New Drug Application	2011-08-24	成都利尔药业有限公司	Chengdu Leer Pharmaceutical Co Ltd	Certificate Issued	2016-09-11	view
CXHL1400214	瑞格列奈胶囊	repaglinide	Capsule	Chemical Drugs(5)	New Drug Application	2014-06-16	海南中化联合制药工业股份有限公司	Double-Crane Pharmaceutical(Hainan) Co Ltd	Certificate Issued	2016-01-29	view
CXHL1400215	瑞格列奈胶囊	repaglinide	Capsule	Chemical Drugs(5)	New Drug Application	2014-06-16	海南中化联合制药工业股份有限公司	Double-Crane Pharmaceutical(Hainan) Co Ltd	Certificate Issued	2016-01-29	view
CXHL1402062	瑞格列奈胶囊	repaglinide	Capsule	Chemical Drugs(5)	New Drug Application	2015-03-19	安徽省先锋制药有限公司	Anhui Pioneer Pharmaceutical Co Ltd	Certificate Issued	2016-10-24	view
CXHL1402064	瑞格列奈胶囊	repaglinide	Capsule	Chemical Drugs(5)	New Drug Application	2015-03-19	安徽省先锋制药有限公司	Anhui Pioneer Pharmaceutical Co Ltd	Certificate Issued	2016-10-24	view
CXHL1402063	瑞格列奈胶囊	repaglinide	Capsule	Chemical Drugs(5)	New Drug Application	2015-03-19	安徽省先锋制药有限公司	Anhui Pioneer Pharmaceutical Co Ltd	Certificate Issued	2016-10-24	view